Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate versus laparoscopic salpingostomy for ectopic pregnancy and fallopian tube patency
IRCT201212121556N49Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of methotrexate in Ectopic pregnancy (EP) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Treatment efficacy for ectopic pregnancy and Fallopian tube patency. Started Dec 2012; status: completed.
02
Drugs
methotrexate
03
Conditions
Ectopic pregnancy (EP)
Beyond the preview
Go deeper on IRCT201212121556N49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201212121556N49.